Premium
Detection of drug‐resistant HIV minorities in clinical specimens and therapy failure
Author(s) -
Louvel S,
Battegay M,
Vernazza P,
Bregenzer T,
Klimkait T,
Hamy F
Publication year - 2008
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/j.1468-1293.2007.00529.x
Subject(s) - resistance mutation , genotyping , medicine , drug resistance , genotype , virology , lamivudine , polymerase chain reaction , allele , hiv drug resistance , human immunodeficiency virus (hiv) , virus , viral load , genetics , biology , antiretroviral therapy , reverse transcriptase , gene , hepatitis b virus
Objective Particularly for therapy‐experienced patients, resistance assessment by genotypic or phenotypic methods produces discordances. This study seeks proof that differences may arise from the fact that genotyping produces a single summary sequence whereas replicative phenotyping (rPhenotyping) functionally detects and assigns resistances in mixed HIV populations. Methods For validation, defined mixes of wild‐type and M184V mutant were analysed by rPhenotyping or standard genotyping. Allele‐specific and quantitative polymerase chain reaction (PCR) set detection and quantification limits for minor virus populations in vitro and in authentic clinical samples showing geno‐/pheno‐discrepant lamivudine resistance. Results Allele‐specific and real‐time PCR methods detected down to 0.3% of mutant M184V. The functional assessment was sensitive enough to reveal <1% of mutant M184V in mixed samples. Also in discordant samples from the diagnostic routine, in which rPhenotyping had identified drug resistance, real‐time PCR confirmed minute amounts of mutant M184V. Conclusion By utilizing the replication dynamics of HIV under drug pressure, a rPhenotyping format potently reveals relevant therapy‐resistant minority species, even of HIV known to possess reduced replicative fitness. With its rapid turnaround of 8 days and its high sensitivity, our rPhenotyping system may be a valuable diagnostic tool for detecting the early emergence of therapy‐threatening HIV minorities or the persistence of residual resistant virus.